Description: MKI-1 is a novel and potent inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM, it exerts antitumor and radiosensitizer activities through PP2A activation in breast cancer.
纯度:≥98%
CAS:1190277-80-5